The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (vol 30, pg 726, 2022)

被引:0
|
作者
Verma, Ankit
Pittala, Srinivas
Alhozeel, Belal
Shteinfer-Kuzmine, Anna
Ohana, Ehud
Gupta, Rajeev
Chung, Jay H.
Shoshan-Barmatz, Varda
机构
关键词
D O I
10.1016/j.ymthe.2024.03.013
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1178 / 1178
页数:1
相关论文
共 50 条
  • [1] The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
    Verma, Ankit
    Pittala, Srinivas
    Alhozeel, Belal
    Shteinfer-Kuzmine, Anna
    Ohana, Ehud
    Gupta, Rajeev
    Chung, Jay H.
    Shoshan-Barmatz, Varda
    MOLECULAR THERAPY, 2022, 30 (02) : 726 - 744
  • [2] Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target
    Camara, Amadou K. S.
    Zhou, Yifan
    Wen, Po-Chao
    Tajkhorshid, Emad
    Kwok, Wai-Meng
    FRONTIERS IN PHYSIOLOGY, 2017, 8
  • [3] Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
    Reddy, P. Hemachandra
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (01): : 67 - 75
  • [4] Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS
    Shteinfer-Kuzmine, Anna
    Argueti-Ostrovsky, Shirel
    Leyton-Jaimes, Marcel F.
    Anand, Uttpal
    Abu-Hamad, Salah
    Zalk, Ran
    Shoshan-Barmatz, Varda
    Israelson, Adrian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [5] Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities
    Hu, Hang
    Guo, Linlin
    Overholser, Jay
    Wang, Xing
    CELLS, 2022, 11 (19)
  • [6] Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology (vol 11, 58, 2022)
    Verma, Ankit
    Shteinfer-Kuzmine, Anna
    Kamenetsky, Nikita
    Pittala, Srinivas
    Paul, Avijit
    Crystal, Edna Nahon
    Ouro, Alberto
    Chalifa-Caspi, Vered
    Pandey, Swaroop Kumar
    Monsonego, Alon
    Vardi, Noga
    Knafo, Shira
    Shoshan-Barmatz, Varda
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [7] Is there a role for therapeutic sphingolipids in inflammatory bowel disease? (vol 12, pg 876, 2020)
    Parigi, T. L.
    Roda, G.
    Argollo, M.
    Gilardi, D.
    Danese, S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (03) : I - I
  • [8] IKKα AS A POTENTIAL THERAPEUTIC TARGET FOR THE PREVENTION OF INFLAMMATORY BOWEL DISEASE
    Tang, Joseph
    Papoutsopoulou, Stamatia
    Paul, Andrew
    MacKay, Professor Simon
    Duckworth, Carrie
    Pritchard, Mark
    GUT, 2021, 70 : A126 - A127
  • [9] Stem Cells in Inflammatory Bowel Disease: New Potential Therapeutic Target
    Song, In Hwan
    Jang, Byung Ik
    INTESTINAL RESEARCH, 2013, 11 (02) : 79 - 84
  • [10] TL1A as a therapeutic target in inflammatory bowel disease
    Kokkotis, Georgios
    Bamias, Giorgos
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (06) : 551 - 555